Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers

被引:196
作者
Flavin, MT
Rizzo, JD
Khilevich, A
Kucherenko, A
Sheinkman, AK
Vilaychack, V
Lin, L
Chen, W
Greenwood, EM
Pengsuparp, T
Pezzuto, JM
Hughes, SH
Flavin, TM
Cibulski, M
Boulanger, WA
Shone, RL
Xu, ZQ
机构
[1] MEDICHEM RES INC, LEMONT, IL 60439 USA
[2] UNIV ILLINOIS, DEPT MED CHEM & PHARMACOGNOSY, PROGRAM COLLABORAT RES PHARMACEUT SCI, CHICAGO, IL 60612 USA
[3] NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA
关键词
D O I
10.1021/jm950797i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The anti-HIV agent (+/-)-calanolide A (1) has been synthesized in a five-step approach starting with phloroglucinol [--> 5 --> 6 --> 11 --> 18 --> (+/-)-1], which includes Pechmann reaction, Friedel-Crafts acylation, chromenylation with 4,4-dimethoxy-2-methylbutan-2-ol, cyclization, and Luche reduction. Cyclization of chromene 11 to chromanone 18 was achieved by employing either acetaldehyde diethyl acetal or paraldehyde in the presence of trifluoroacetic acid and pyridine or PPTS. Luche reduction of chromanone 18 at lower temperature preferably yielded (+/-)-1. Reduction of chromone 12, synthesized by Kostanecki-Robinson reaction from chromene 11, failed to afford (+/-)-1. The synthetic (+/-)-1 has been chromatographically resolved into its optically active forms, (+)- and (-)-1. The anti-HIV activities for synthetic (+/-)-1, as well as resultant (+)- and (-)-1, have been determined. Only (+)-1 accounted for anti-HIV activity, which was similar to the data reported for the natural product, and (-)-1 was inactive.
引用
收藏
页码:1303 / 1313
页数:11
相关论文
共 76 条
[1]  
AHLUWALIA VK, 1975, INDIAN J CHEM, V13, P546
[2]  
ARNOLD E, 1991, ADV VIRUS RES, V39, P1
[3]   TOTAL SYNTHESIS OF ISOROBUSTIN [J].
BARTON, DHR ;
DONNELLY, DMX ;
FINET, JP ;
GUIRY, PJ .
TETRAHEDRON LETTERS, 1990, 31 (51) :7449-7452
[4]   ANALYSIS OF NONNUCLEOSIDE DRUG-RESISTANT VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
BOYER, PL ;
CURRENS, MJ ;
MCMAHON, JB ;
BOYD, MR ;
HUGHES, SH .
JOURNAL OF VIROLOGY, 1993, 67 (04) :2412-2420
[5]  
BRAUN MM, 1990, ANNU REV MICROBIOL, V44, P555
[6]   RECONSTRUCTION AND FUTURE-TRENDS OF THE AIDS EPIDEMIC IN THE UNITED-STATES [J].
BROOKMEYER, R .
SCIENCE, 1991, 253 (5015) :37-42
[7]   COMPARITIVE ANTI-HIV EVALUATION OF DIVERSE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT VIRUS ISOLATES DEMONSTRATES THE EXISTENCE OF DISTINCT PHENOTYPIC SUBGROUPS [J].
BUCKHEIT, RW ;
FLIAKASBOLTZ, V ;
DECKER, WD ;
ROBERSON, JL ;
STUP, TL ;
PYLE, CA ;
WHITE, EL ;
MCMAHON, JB ;
CURRENS, MJ ;
BOYD, MR ;
BADER, JP .
ANTIVIRAL RESEARCH, 1995, 26 (02) :117-132
[8]   SAMARIUM(II) IODIDE-HMPA - A VERY EFFICIENT SYSTEM FOR THE SELECTIVE REDUCTION OF ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS [J].
CABRERA, A ;
ALPER, H .
TETRAHEDRON LETTERS, 1992, 33 (35) :5007-5008
[9]   RESOLUTION AND COMPARATIVE ANTI-HIV EVALUATION OF THE ENANTIOMERS OF CALANOLIDE-A AND CALANOLIDE-B [J].
CARDELLINA, JH ;
BOKESCH, HR ;
MCKEE, TC ;
BOYD, MR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (09) :1011-1014
[10]   TOTAL SYNTHESIS OF (PLUS-OR-MINUS)-CALANOLIDE-A, A NON-NUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE [J].
CHENERA, B ;
WEST, ML ;
FINKELSTEIN, JA ;
DREYER, GB .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (21) :5605-5606